(S1 (S (S (NP (NP (JJ H-ras) (NNS mutations)) (PP (IN in) (NP (JJ human) (NN pituitary) (NN carcinoma) (NNS metastases))))) (. .)))
(S1 (S (S (NP (NP (JJ Molecular) (NNS mechanisms)) (PP (IN of) (NP (JJ pituitary) (NN tumorigenesis)))) (VP (VBD were) (VP (VBN studied) (S (VP (VBG using) (NP (NP (NN Polymerase) (NN chain) (NN reaction-single) (JJ stranded) (JJ conformational) (NN polymorphism)) (PP (IN with) (NP (NN DNA) (NN sequencing)))) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ potential) (NNS mutations)) (PP (IN in) (NP (NP (DT the) (NP (NN ras) (NNS protooncogenes)) (CC and) (NP (DT the) (NN tumor) (NN suppressor) (NN gene) (NN p53))) (PP (IN in) (NP (NP (JJ invasive) (JJ pituitary) (NNS adenomas)) (CC and) (NP (NNS carcinomas))))))))))))))) (. .)))
(S1 (S (NP (NP (NN Sequencing)) (PP (IN of) (NP (NNS exons) (QP (CD 5) (IN through) (CD 8)) (PP (IN of) (NP (DT the) (NN p53) (NN gene)))))) (VP (VP (VBD revealed) (NP (DT no) (NNS mutations))) (, ,) (CC nor) (VP (VBD were) (NP (NP (NNS mutations)) (VP (VBN detected) (PP (IN in) (NP (DT the) (NP (NN N-)) (CC or) (NP (NN K-ras) (NNS protooncogenes)))) (PP (IN in) (NP (NP (NP (CD four)) (PP (IN of) (NP (DT the) (NNS carcinomas)))) (CC and) (NP (PRP$ their) (JJ respective) (JJ metastatic) (NNS deposits)))))))) (. .)))
(S1 (S (S (NP (NP (NN Point) (NNS mutations)) (PP (IN of) (NP (NN H-ras)))) (ADVP (RB however)) (, ,) (VP (VBD were) (VP (VBN identified) (PP (PP (IN in) (NP (CD three) (JJ distant) (JJ metastatic) (NN pituitary) (NN tumor) (NNS secondaries))) (, ,) (CC but) (RB not) (PP (IN in) (NP (PRP$ their) (JJ respective) (JJ primary) (NN pituitary) (NNS carcinomas))) (, ,) (CC or) (PP (IN in) (NP (CD six) (JJ invasive) (NNS adenomas))))))) (. .)))
(S1 (S (S (NP (NP (CD Two)) (PP (IN of) (NP (DT the) (NNS mutations)))) (VP (VBD included) (NP (NP (NP (DT a) (NN G)) (PP (TO to) (NP (NP (NN C) (NN substitution)) (PP (IN at) (NP (NN codon) (CD 12)))))) (, ,) (CC and) (NP (NP (DT a) (NN G)) (PP (TO to) (NP (NP (DT A) (NN substitution)) (PP (IN at) (NP (NN codon) (CD 18))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (DT a) (NN glycine)) (PP (TO to) (NP (NN arginine)))) (, ,) (CC and) (NP (NP (DT an) (NN alanine)) (PP (TO to) (NP (NN threonine) (NN change))) (PP (IN at) (NP (DT these) (NN amino) (NNS acids)))) (, ,) (ADVP (RB respectively)))))))) (. .)))
(S1 (S (S (NP (DT A) (JJ third) (NN mutation)) (VP (VBD involved) (NP (NP (DT a) (JJ single) (NN base) (NN pair) (-LRB- -LRB-) (NN adenine) (-RRB- -RRB-) (NN deletion)) (PP (IN in) (NP (NP (NN codon) (CD 3)) (PP (IN of) (NP (NN H-ras))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ causes) (NP (DT a) (NN frame) (NN shift)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (NN termination) (NN signal)) (PP (IN at) (NP (NN codon) (CD 19))))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (NP (NN point) (NNS mutations)) (PP (IN in) (NP (NP (NN p53)) (CC and) (NP (NN ras))))) (VP (VBP are) (RB not) (VP (VBN associated) (PP (IN with) (NP (JJ pituitary) (NN tumorigenesis)))))) (, ,) (S (ADVP (RB however)) (, ,) (NP (NP (NN point) (NNS mutations)) (PP (IN of) (NP (DT the) (NN H-ras) (NN gene)))) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NP (NN formation)) (CC and) (NP (NN or) (NN growth))) (PP (IN of) (NP (JJ pituitary) (NNS metastases))))))))))))) (. .)))
(S1 (S (S (NP (DT This) (VBN observed) (JJ genomic) (NN instability)) (VP (MD will) (VP (VB be) (PP (IN of) (NP (NN value))) (PP (IN in) (S (VP (VBG predicting) (NP (NP (DT the) (JJ potential) (JJ metastatic) (NN behavior)) (PP (IN of) (NP (DT these) (JJ aggressive) (JJ pituitary) (NNS tumors)))))))))) (. .)))
